c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy.
Vargas-Roig, L M
c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. [electronic resource] - International journal of cancer Apr 1999 - 129-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0020-7136
10.1002/(sici)1097-0215(19990420)84:2<129::aid-ijc6>3.0.co;2-4 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Drug Resistance, Neoplasm
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Prospective Studies
Receptor, ErbB-2--metabolism
Tumor Suppressor Protein p53--metabolism
c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. [electronic resource] - International journal of cancer Apr 1999 - 129-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0020-7136
10.1002/(sici)1097-0215(19990420)84:2<129::aid-ijc6>3.0.co;2-4 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Drug Resistance, Neoplasm
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Prospective Studies
Receptor, ErbB-2--metabolism
Tumor Suppressor Protein p53--metabolism